YONGHE MEDICAL released its interim results, with a profit attributable to shareholders of HKD 27.913 million, turning a profit compared to the same period last year
I'm LongbridgeAI, I can summarize articles.YONGHE MEDICAL released its interim results for the period ending June 30, 2025, with group revenue of 862 million yuan, gross profit of 550 million yuan, and profit attributable to shareholders of 27.913 million yuan, turning a profit compared to the previous year, with earnings per share of 0.06 yuan. The company focuses on hair medical services and operates 63 hair transplant medical institutions, serving a total of 64,845 consumers
According to the Zhitong Finance APP, YONGHE MEDICAL (02279) announced its interim results for the six months ending June 30, 2025, with group revenue of RMB 862 million; gross profit of RMB 550 million, an increase of 3.9% year-on-year; profit attributable to shareholders of RMB 27.913 million, turning from loss to profit year-on-year; and earnings per share of RMB 0.06.
As a leading medical group in China specializing in hair medical services, the company provides a one-stop hair medical service covering hair transplantation, medical hair maintenance, routine care, and other supporting services. The company has been focused on the hair medical service market and has built a full industry chain brand matrix centered around "YONGHE MEDICAL," consisting of the professional hair transplant brand "YONGHE Hair Transplant," the medical hair maintenance brand "Shiyunxun," the women's aesthetic hair transplant brand "YONGHE Hair Origin," and the medical wig brand "Hafada." As of June 30, 2025, the company has 63 hair transplant medical institutions in 61 cities nationwide and 6 Shiyunxun hair health institutions in Shenzhen, Shanghai, and Guangzhou, making it the largest and most widely covered chain hair medical group in China. As of the six months ending June 30, 2025, the total number of consumers served by the company reached 64,845